Education
About Us
Working with TipRanks
Follow Us
Timothy Eugene Sullivan Insider Profile
4 Followers
Timothy Eugene Sullivan, CFO at Apellis Pharmaceuticals, holds 171.33K shares in Apellis Pharmaceuticals (Ticker: APLS).
Timothy Eugene Sullivan Apellis Pharmaceuticals (APLS)CFO
Apellis Pharmaceuticals (APLS)
CFO
Ranked #7,267 out of 103,431 Corporate Insiders
Profitable Transactions
7 out of 8 Profitable Transactions
Average Return
+30.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Timothy Eugene Sullivan's holdings
Insider Roles
CFO
Roles that Timothy Eugene Sullivan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 13, 2024 - Feb 13, 2025
Return:+58.50%
The most profitable trade made by Timothy Eugene Sullivan
Timothy Eugene Sullivan's Trading History
List of latest transactions for each holding click on a transaction to see Timothy Eugene Sullivan's performance on stock
You May Also Like
Timothy Eugene Sullivan insider profile FAQ
What is the percentage of profitable transactions made by Timothy Eugene Sullivan?
The percentage of profitable transactions made by Timothy Eugene Sullivan is 88%.
What is the average return per transaction made by Timothy Eugene Sullivan?
The average return per transaction made by Timothy Eugene Sullivan is 30.20%.
What stocks does Timothy Eugene Sullivan hold?
Timothy Eugene Sullivan holds: APLS stocks.
What was Timothy Eugene Sullivan’s latest transaction?
Timothy Eugene Sullivan latest transaction was an Uninformative Buy of $150.45K.
What was Timothy Eugene Sullivan's most profitable transaction?
Timothy Eugene Sullivan’s most profitable transaction was an Informative Sell of APLS stock on February 13, 2024. The return on the trade was 58.50%.
What is Timothy Eugene Sullivan's role in Apellis Pharmaceuticals?
Timothy Eugene Sullivan's role in Apellis Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.